Who is sponsoring NCT05260268?

NCT05260268 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT05260268?

Interventions in NCT05260268: TEST Intervention.

What condition does NCT05260268 study?

NCT05260268 studies Liver Transplant; Complications, Cirrhosis, End Stage Liver DIsease, Medication Adherence.

Is NCT05260268 still recruiting?

NCT05260268 is currently recruiting now. Last updated 16 May 2025.

Last reviewed 2025-05-16 · How we verify

NCT05260268: TEST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

Recruiting now NA Last updated 16 May 2025

What this trial tests

NA trial testing TEST Intervention in Liver Transplant; Complications in 360 participants. Currently enrolling.

Timeline

1 December 2022

Primary endpoint
1 July 2026

1 January 2027

Quick facts

Lead sponsor	University of Pennsylvania
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	360
Start date	1 December 2022
Primary completion	1 July 2026
Estimated completion	1 January 2027
Sites	3 locations across United States

Drugs / interventions tested

TEST Intervention

Conditions studied

Liver Transplant; Complications — all drugs for Liver Transplant; Complications →
Cirrhosis — all drugs for Cirrhosis →
End Stage Liver DIsease — all drugs for End Stage Liver DIsease →
Medication Adherence — all drugs for Medication Adherence →

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Liver Transplant; Complications or Cirrhosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Liver transplantation is increasingly performed for older adults with multiple comorbidities. Medication adherence is key to maintaining proper function of the transplanted liver and optimize health; however, adhering to post-transplant treatment is complex. This trial will study how available technology combined with transplant center resources and caregiver support can optimize medication adherence, quality of life, and health outcomes among new liver transplant recipients at 3 centers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Patient randomised controlled trial of technology enabled strategies to promote treatment adherence in liver transplantation: rationale and design of the TEST trial.
Serper M, Burdzy A, Schaubel DE, Mason R, et al · · 2023 · cited 5× · PMID 37723108 · DOI 10.1136/bmjopen-2023-075172

Verify or expand the search:

Other recruiting trials for Liver Transplant; Complications

Currently open trials in the same condition.

NCT06257407 — Perioperative Hemostasis Management in Liver Transplantation · recruiting
NCT06533592 — The Effect of the Type of Conduit-duct Anastomosis Technique on the Postoperative Course in Patients Undergoing Liver Tr · NA · recruiting
NCT06400771 — Safety of DNP007 in Healthy Subjects · Phase 1 · recruiting
NCT06386198 — HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients · NA · recruiting
NCT06236568 — Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation · NA · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05260268 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 16 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05260268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing